← FDA DRUG APPROVALS

FDA ANDA · ANDA088792

DISULFIRAM

Sponsor: STRIDES PHARMA INTL

APPLICATION
ANDA088792
TYPE
ANDA
ORIGINAL APPROVAL
1984-08-14
LATEST ACTION
2009-06-04
ROUTE
ORAL
DOSAGE FORM
TABLET
MARKETING STATUS
Discontinued

Products

DISULFIRAMDiscontinued
DISULFIRAM 250MG · TABLET · ORAL

Approval history

2009-06-04Labeling · Supplement 9AP
2009-04-03Labeling · Supplement 8AP
1989-01-10Labeling · Supplement 7AP
1987-02-10Manufacturing (CMC) · Supplement 2AP
1987-01-08Manufacturing (CMC) · Supplement 3AP
1987-01-08Manufacturing (CMC) · Supplement 4AP
1984-08-14OriginalAP
VIEW ON DRUGS@FDA ↗

Related on SPEQ

Pharma industry →GMP discipline →FDA drug shortages →FDA enforcement & recalls →

Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.

Weekly Briefing

Get the Weekly GxP Briefing

Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.

Read a past issue →